A

Apeloa Pharmaceutical Co Ltd
SZSE:000739

Watchlist Manager
Apeloa Pharmaceutical Co Ltd
SZSE:000739
Watchlist
Price: 15.66 CNY 1.95% Market Closed
Market Cap: 18.2B CNY
Have any thoughts about
Apeloa Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is 24.47 CNY. Compared to the current market price of 15.66 CNY, Apeloa Pharmaceutical Co Ltd is Undervalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
24.47 CNY
Undervaluation 36%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
Apeloa Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Apeloa Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Apeloa Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Apeloa Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Apeloa Pharmaceutical Co Ltd.

What unique competitive advantages
does Apeloa Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Apeloa Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Apeloa Pharmaceutical Co Ltd.

Provide P/S
for Apeloa Pharmaceutical Co Ltd.

Provide P/E
for Apeloa Pharmaceutical Co Ltd.

Provide P/OCF
for Apeloa Pharmaceutical Co Ltd.

Provide P/FCFE
for Apeloa Pharmaceutical Co Ltd.

Provide P/B
for Apeloa Pharmaceutical Co Ltd.

Provide EV/S
for Apeloa Pharmaceutical Co Ltd.

Provide EV/GP
for Apeloa Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Apeloa Pharmaceutical Co Ltd.

Provide EV/EBIT
for Apeloa Pharmaceutical Co Ltd.

Provide EV/OCF
for Apeloa Pharmaceutical Co Ltd.

Provide EV/FCFF
for Apeloa Pharmaceutical Co Ltd.

Provide EV/IC
for Apeloa Pharmaceutical Co Ltd.

Show me price targets
for Apeloa Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Apeloa Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Apeloa Pharmaceutical Co Ltd?

What are the Net Income projections
for Apeloa Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Apeloa Pharmaceutical Co Ltd?

What are the EPS projections
for Apeloa Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Apeloa Pharmaceutical Co Ltd?

What are the EBIT projections
for Apeloa Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Apeloa Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Apeloa Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Apeloa Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Apeloa Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Apeloa Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Apeloa Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Apeloa Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Apeloa Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Apeloa Pharmaceutical Co Ltd.

Provide ROE
for Apeloa Pharmaceutical Co Ltd.

Provide ROA
for Apeloa Pharmaceutical Co Ltd.

Provide ROIC
for Apeloa Pharmaceutical Co Ltd.

Provide ROCE
for Apeloa Pharmaceutical Co Ltd.

Provide Gross Margin
for Apeloa Pharmaceutical Co Ltd.

Provide Operating Margin
for Apeloa Pharmaceutical Co Ltd.

Provide Net Margin
for Apeloa Pharmaceutical Co Ltd.

Provide FCF Margin
for Apeloa Pharmaceutical Co Ltd.

Show all solvency ratios
for Apeloa Pharmaceutical Co Ltd.

Provide D/E Ratio
for Apeloa Pharmaceutical Co Ltd.

Provide D/A Ratio
for Apeloa Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Apeloa Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Apeloa Pharmaceutical Co Ltd.

Provide Quick Ratio
for Apeloa Pharmaceutical Co Ltd.

Provide Current Ratio
for Apeloa Pharmaceutical Co Ltd.

Provide Cash Ratio
for Apeloa Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Apeloa Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Apeloa Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Apeloa Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Apeloa Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Apeloa Pharmaceutical Co Ltd

Current Assets 9.1B
Cash & Short-Term Investments 2.8B
Receivables 2.9B
Other Current Assets 3.4B
Non-Current Assets 4.5B
Long-Term Investments 181.7m
PP&E 3.7B
Intangibles 334.5m
Other Non-Current Assets 241m
Current Liabilities 7B
Accounts Payable 2.2B
Accrued Liabilities 187.8m
Short-Term Debt 3.9B
Other Current Liabilities 666.4m
Non-Current Liabilities 218.2m
Long-Term Debt 12.9m
Other Non-Current Liabilities 205.3m
Efficiency

Earnings Waterfall
Apeloa Pharmaceutical Co Ltd

Revenue
11.9B CNY
Cost of Revenue
-9.1B CNY
Gross Profit
2.9B CNY
Operating Expenses
-1.7B CNY
Operating Income
1.2B CNY
Other Expenses
-99.6m CNY
Net Income
1.1B CNY

Free Cash Flow Analysis
Apeloa Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Apeloa Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
55/100
Profitability
Score

Apeloa Pharmaceutical Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Apeloa Pharmaceutical Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
59/100
Solvency
Score

Apeloa Pharmaceutical Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Apeloa Pharmaceutical Co Ltd

Wall Street analysts forecast Apeloa Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Apeloa Pharmaceutical Co Ltd is 20.4 CNY with a low forecast of 20.2 CNY and a high forecast of 21 CNY.

Lowest
Price Target
20.2 CNY
29% Upside
Average
Price Target
20.4 CNY
30% Upside
Highest
Price Target
21 CNY
34% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Apeloa Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Apeloa Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Apeloa Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

18.3B CNY

Dividend Yield

2.02%

Description

Apeloa Pharmaceutical Co., Ltd. engages in research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and preparations. The company is headquartered in Jinhua, Zhejiang and currently employs 6,133 full-time employees. The Company’s main products consist of bulk drugs, intermediates, chemical preparations, as well as Chinese traditional medicine preparations, such as ubenimex capsules, cefixime, amantadine and others. The firm distributes its businesses in domestic market and to overseas markets.

Contact

ZHEJIANG
Jinhua
No. 333, Jiangnan Road, Hengdian, Dongyang City
+8657986557527
www.apeloa.com

IPO

1997-05-09 00:00:00

Employees

6 133

Officers

Chairman
Mr. Fangmeng Zhu
General Manager
Mr. Chun He
Vice Chairman
Mr. Xinliang Xu
Chief Financial Officer
Mr. Jinhui Zhang
Senior Deputy GM & GM of API Division
Mr. Min Jin
Deputy GM & GM of CDMO Division
Mr. Lei Cai
Show More
Deputy GM & Secretary
Mr. Yuwang Zhou
Chief Technology Officer
Mr. Hui Zhang
Show Less

See Also

Discover More
What is the Intrinsic Value of one Apeloa Pharmaceutical Co Ltd stock?

The intrinsic value of one Apeloa Pharmaceutical Co Ltd stock under the Base Case scenario is 24.47 CNY.

Is Apeloa Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 15.66 CNY, Apeloa Pharmaceutical Co Ltd is Undervalued by 36%.

Back to Top